Andrei A Bunaciu^1*, Hassan Y Aboul-Enein²

¹Department of Infrared Spectroscopy, Bunaciu Andrei - P.F.A (A.N.P.), Bragadiru – Ilfov District, 077025, Romania
²Pharmaceutical and Medicinal Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Center, Cairo 12622, Egypt

*Corresponding Author: Andrei A Bunaciu, S1Department of Infrared Spectroscopy, Bunaciu Andrei - P.F.A (A.N.P.), Bragadiru – Ilfov District, 077025, Romania.

Received: March 05, 2026; Published: May 07, 2026

Many acute and chronic illnesses are becoming more prevalent as the world’s population ages and the medical field undergoes rapid change. As a result, there is a growing need for “point-of-care” (POC) identification/detection and real-time management of health issues that have been necessary for a long time. The human body develops many deadly illnesses in silence, with symptoms only showing up after the disease is far advanced. Vibrational spectroscopic (infrared and Raman) techniques in biofluids have advanced clinical diagnosis and prognosis; this review aims to demonstrate this development through a thorough literature assessment. IR (infrared) technology offers a suitable limit of detection for real-time, non-invasive, and non-destructive examination of organic substances. This review aims to compile the most relevant applications of infrared spectroscopy published between 2020 and 2026 that assess gait characteristics and related algorithms, demonstrating potential for assisting in disease diagnosis and symptom monitoring.

Keywords: Infrared Spectroscopy; Biomedical Analysis; Monitoring Disease Treatment

References

1. Farrokhi M., et al. “Artificial Intelligence for Remote Patient Monitoring: Advancements, Applications, and Challenges”. 4.1 (2024): 1-261.
2. Freddie Bray ML., et al. “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians3 (2024): 229-263.
3. Dimitriadou I., et al. “Measuring Patient-Reported Outcomes in Ischemic Heart Disease: Validation of the Greek HeartQoL Questionnaire”. American Journal of Medicine Open 14 (2025): 100098.
4. Chagas GCL., et al. “Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: A systematic review and meta-analysis of randomized controlled trials”. Diabetes Research Clinical Practice (2025): 111986.
5. Theakstone AG., et al. “Fourier‐transform infrared spectroscopy of biofluids: A practical approach”. Journal of Translational Biophotonics 2 (2021): e202000025.
6. Delrue C., et al. “The Promise of Infrared Spectroscopy in Liquid Biopsies for Solid Cancer Detection”. Diagnostics (Basel) 3 (2025): 368.
7. Moertel CG and Hanley JA. “The effect of measuring error on the results of therapeutic trials in advanced cancer”. Cancer 1 (1976): 388-94.
8. Bonilauri A., et al. “A systematic review of cerebral functional near-infrared spectroscopy in chronic neurological diseases—actual applications and future perspectives”. Diagnostics (Basel)8 (2020): 581.
9. Di Biase L., et al. “Gait analysis in Parkinson’s disease: An overview of the most accurate markers for diagnosis and symptoms monitoring”. Sensors 12 (2020): 3529.
10. Su K-Y and Lee W-L. “Fourier transform infrared spectroscopy as a cancer screening and diagnostic tool: A review and prospects”. Cancers1 (2020): 115.
11. Alsunaidi B., et al. “A review of non-invasive optical systems for continuous blood glucose monitoring”. Sensors20 (2021): 6820.
12. Wang N., et al. “Functional near-infrared spectroscopy for the assessment and treatment of patients with disorders of consciousness”. Frontiers in Neurology 16 (2025): 1524806.
13. Oh H-H and Joo Y-E. “Novel biomarkers for the diagnosis and prognosis of colorectal cancer”. Intestinal Research 2 (2020): 168-83.
14. Bunaciu AA and Aboul-Enein HY. “Advancements in Early Disease Diagnosis Using FTIR Spectroscopy of Body Fluid”. Achievements and Challenges of Medicine and Medical Science 13 (2025): 43-69.
15. Rumaling MI., et al. “Methods of optical spectroscopy in detection of virus in infected samples: A review”. Heliyon 9 (2022): e10472.
16. Bedair A., et al. “Spectroscopic methods for COVID-19 detection and early diagnosis”. Virology Journal1 (2022): 152.
17. Antelo-Riveiro P., et al. “Rapid diagnosis and severity scale of post-COVID condition using advanced spectroscopy”. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 328 (2025): 125474.
18. Moscoso A., et al. “Frequency and clinical outcomes associated with tau positron emission tomography positivity”. JAMA3 (2025): 229-242.
19. Fazekas T., et al. “Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis”. JAMA Oncology6 (2024): 745-754.
20. Monticciolo DL., et al. “Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR”. Journal of the American College of Radiology9 (2023): 902-914.
21. Guo J and Xue Y. “Application of magnetic resonance imaging and artificial intelligence algorithms in cancer screening”. SLAS Technology6 (2024): 100218.
22. Surkova A., et al. “Near‐Infrared Spectroscopy and Aquaphotomics in Cancer Research: A Pilot Study”. Journal of Chemometrics12 (2024): e3600.
23. Goderska K., et al. “Helicobacter pylori treatment: antibiotics or probiotics”. Applied Microbiology and Biotechnology 1 (2018): 1-7.
24. Kuipers EJ. “Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer”. Alimentary Pharmacology and Therapeutics1 (1974): 71-88.
25. Elbehiry A., et al. “Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges”. Antibiotics2 (2023): 191.
26. Debraekeleer A and Remaut H. “Future perspective for potential Helicobacter pylori eradication therapies”. Future Microbiology 13 (2018): 671-687.
27. Maiti KS and Apolonski A. “Monitoring the Reaction of the Body State to Antibiotic Treatment against Helicobacter pylori via Infrared Spectroscopy: A Case Study”. Molecules11 (2021): 3474.
28. Apolonski A and Maiti KS. “Towards a standard operating procedure for revealing hidden volatile organic compounds in breath: the Fourier-transform IR spectroscopy case”. Applied Optics14 (2021): 4217-4224.
29. Bunaciu AA and Aboul-Enein HY. “A Review of FTIR Spectroscopy Used in COVID-19 Analysis”. Medical Science: Recent Advances and Applications 5 (2025): 86-106.
30. de Fátima Cobre A., et al. “Accuracy of COVID-19 diagnostic tests via infrared spectroscopy: A systematic review and meta-analysis”. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (2024): 125337.
31. Huang J-D., et al. “Detecting Respiratory Viruses Using a Portable NIR Spectrometer—A Preliminary Exploration with a Data Driven Approach”. Sensors1 (2024): 308.
32. Anjos VP., et al. “Fourier Transform Infrared Spectroscopy-Based Detection of Amoxicillin and Ampicillin for Advancing Antibiotic Monitoring with Optical Techniques”. 35.1 (2025): 7.
33. Ashcroft Frances M., et al. “Diabetes Mellitus and the β Cell: The Last Ten Years”. Cell6 (2012): 1160-1171.
34. Li T., et al. “Infrared absorption spectroscopy-based non-invasive blood glucose monitoring technology: A comprehensive review”. Biomedical Signal Processing and Control 106 (2025): 107750.
35. San-Millán I. “The key role of mitochondrial function in health and disease”. Antioxidants (Basel)4 (2023): 782.
36. Sakran N., et al. “The many faces of diabetes. Is there a need for re-classification? A narrative review”. BMC Endocrine Disorders1 (2022): 9.
37. Lu X., et al. “Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy”. Signal Transduction Targeted Therapy1 (2024): 262.
38. Poznyak A., et al. “The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation”. 21.5 (2020): 1835.
39. Chitneni A., et al. “Early Detection of Diabetic Peripheral Neuropathy by fMRI: An Evidence-Based Review”. Brain Sciences5 (2022).
40. Liccardo D., et al. “Periodontal disease: a risk factor for diabetes and cardiovascular disease”. 20.6 (2019): 1414.
41. Yamazaki T., et al. “Treatment of diabetic kidney disease: current and future”. 45.1 (2021): 11-26.
42. Cole JB and Florez JC. “Genetics of diabetes mellitus and diabetes complications”. 16.7 (2020): 377-390.
43. Tomic D., et al. “The burden and risks of emerging complications of diabetes mellitus”. 18.9 (2022): 525-539.
44. Contreras-Rozo JA., et al. “Infrared spectroscopy technique: An alternative technology for diabetes diagnosis”. Biomedical Signal Processing Control 86 (2023): 105246.
45. Caixeta DC., et al. “Salivary molecular spectroscopy: A sustainable, rapid and non-invasive monitoring tool for diabetes mellitus during insulin treatment”. PLoS One3 (2020): e0223461.
46. Hina A and Saadeh W. “Noninvasive blood glucose monitoring systems using near-infrared technology—A review”. Sensors 13 (2022): 4855.
47. Committee ADAPP. “Glycemic Targets: Standards of Medical Care in Diabetes—2022”. Diabetes Care (2021): S83-S96.
48. Cosentino F., et al. “2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)”. 41.2 (2020): 255-323.
49. Monnier L., et al. “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes”. 295.14 (2016): 1681-1687.
50. Zoungas S., et al. “Severe hypoglycemia and risks of vascular events and death”. The New England Journal of Medicine15 (2010): 1410-1418.
51. Kataoka Y., et al. “The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial”. Journal of Diabetes and its Complications10 (2023): 108592.
52. Nicholls SJ., et al. “Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome”. Journal of the American College of Cardiology21 (2010): 2399-2407.
53. Waksman R., et al. “Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study”. The Lancet10209 (2019): 1629-1637.
54. Naseer K., et al. “ATR-FTIR spectroscopy as the future of diagnostics: a systematic review of the approach using bio-fluids”. Applied Spectroscopy Reviews2 (2021): 85-97.
55. Perez-Guaita D., et al. “Quantification and Identification of Microproteinuria Using Ultrafiltration and ATR-FTIR Spectroscopy”. Analytical Chemistry3 (2020): 2409-2416.
56. Lin TL., et al. “Assessment of Measurement of Salivary Urea by ATR-FTIR Spectroscopy to Screen for CKD”. Kidney 3602 (2022): 357-363.
57. Oliver KV., et al. “Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria”. Scientific Report 6 (2016): 34737.
58. Farooq S and Zezell DM. “Diabetes monitoring through urine analysis using ATR-FTIR spectroscopy and machine learning”. Chemosensors 11 (2023): 565.
59. Nogueira MS., et al. “FTIR spectroscopy as a point of care diagnostic tool for diabetes and periodontitis: A saliva analysis approach”. Photodiagnosis and Photodynamic Therapy 40 (2022): 103036.
60. Bray F., et al. “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians 3 (2024): 229-263.
61. Epstein JB., et al. “Advances in the diagnosis of oral premalignant and malignant lesions”. 68.10 (2002): 617-21.
62. Khanmohammadi M., et al. “Application of linear discriminant analysis and Attenuated Total Reflectance Fourier Transform Infrared microspectroscopy for diagnosis of colon cancer”. Pathology Oncology Research : POR 2 (2011): 435-441.
63. Le Naour F., et al. “In situ chemical composition analysis of cirrhosis by combining synchrotron fourier transform infrared and synchrotron X-ray fluorescence microspectroscopies on the same tissue section”. Analytical Chemistry 23 (2012): 10260-10266.
64. Rajendran A., et al. “Molecular imaging biomarkers of the tumour microenvironment: Advances in early cancer detection and treatment response monitoring”. Advances in Biomarker Sciences and Technology 8 (2026): 254-268.
65. Petibois C and Déléris G. “Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathology”. Trends in Biotechnology 10 (2006): 455-462.
66. Baker MJ., et al. “Using Fourier transform IR spectroscopy to analyze biological materials”. Nature Protocols 8 (2014): 1771-1791.
67. Kepesidis KV., et al. “Assessing lung cancer progression and survival with infrared spectroscopy of blood serum”. 23.1 (2025): 101.
68. Tarek Eissa LV., et al. “The Perils of Molecular Interpretations from Vibrational Spectra of Complex Samples”. Angew Chem Int Ed Engl 63 (2024): e202411596.
69. Huber M., et al. “Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring”. Nature Communications1 (2021): 1511.
70. Voronina L., et al. “Molecular origin of blood-based infrared fingerprints”. arXiv preprint arXiv (2021): 00765.
71. Yu G. “Near-infrared diffuse correlation spectroscopy in cancer diagnosis and therapy monitoring”. Journal of Biomedical Optics1 (2012): 010901.
72. Kondepati VR., et al. “Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy”. Analytical and Bioanalytical Chemistry1 (2008): 125-139.
73. Chen H., et al. “Near-Infrared Spectroscopy as a Diagnostic Tool for Distinguishing between Normal and Malignant Colorectal Tissues”. Biomed Research International1 (2015): 472197.
74. Hands JR., et al. “Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy”. Journal of Neuro-oncology3 (2016): 463-472.
75. Sun X., et al. “Detection of lung cancer tissue by attenuated total reflection–Fourier transform infrared spectroscopy—a pilot study of 60 samples”. Journal of Surgical Research1 (2013): 33-38.
76. Cameron JM., et al. “A spectroscopic liquid biopsy for the earlier detection of multiple cancer types”. British Journal of Cancer10 (2023): 1658-1666.
77. Li L., et al. “Fourier transform infrared spectroscopy: An innovative method for the diagnosis of ovarian cancer”. Cancer Management Research Bulletin, Ain Shams Univ (2021): 2389-2399.
78. Paraskevaidi M., et al. “Clinical applications of infrared and Raman spectroscopy in the fields of cancer and infectious diseases”. 56.8-10 (2021): 804-868.
79. Zhu J., et al. “FTIR spectroscopy for assessment of hair from lung cancer patients and its application in monitoring the chemotherapy treatment effect”. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 314 (2024): 124185.
80. Di Santo R., et al. “Exploring novel circulating biomarkers for liver cancer through extracellular vesicle characterization with infrared spectroscopy and plasmonics”. 1319 (2024): 342959.
81. Esposito R., et al. “Monitoring Biochemical Changes of Neuroblastoma Cells in Early Stages After X-Ray Exposure by Using Fourier-Transform Infrared Spectroscopy”. Sensors23 (2024): 7459.

Citation

Citation: Andrei A Bunaciu and Hassan Y Aboul-Enein. “FTIR Spectroscopy Used in Disease Treatment Monitoring". Acta Scientific Medical Sciences 10.5 (2026): 42-55.

Copyright

Copyright: © 2026 Andrei A Bunaciu and Hassan Y Aboul-Enein. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.